Basics Cytokinetics, Incorporated Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. IPO Date: May 1, 2004 Sector: Healthcare Industry: Biotech Market Cap: $8.03B Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 2.81% Avg Daily Range (30 D): $1.30 | 2.07% Avg Daily Range (90 D): $1.14 | 2.20% Institutional Daily Volume Avg Daily Volume: .58M Avg Daily Volume (30 D): 1.5M Avg Daily Volume (90 D): 1.76M Trade Size Avg Trade Size (Sh.): 103 Avg Trade Size (Sh.) (30 D): 60 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 7,754 Avg Inst. Trade: $3.31M Avg Inst. Trade (30 D): $4.38M Avg Inst. Trade (90 D): $3.83M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $6.91M Avg Closing Trade (30 D): $12.26M Avg Closing Trade (90 D): $12.87M Avg Closing Volume: 174.84K     News Dec 2, 2025 @ 5:39 PM Important Notice to Long-Term Shareholders of Cyto... Source: Joshua H. Grabar Nov 25, 2025 @ 6:00 PM Chronic Heart Failure Clinical Trial Pipeline Show... Source: Delveinsight Nov 16, 2025 @ 5:00 PM CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc Nov 16, 2025 @ 12:52 AM CYTK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Enc... Source: Rosen Law Firm Nov 14, 2025 @ 9:00 PM aTyr Pharma, Inc. Class Action: Levi & Korsinsky R... Source: Levi & Korsinsky, Llp Financials   TTM Q3 2025 Q2 2025 Basic EPS $-2.55 $-1.12 Diluted EPS $-2.55 $-1.12 Revenue $ $ 1.94M $ 66.77M Gross Profit $ $ $ Net Income / Loss $ $ -306.18M $ -134.37M Operating Income / Loss $ $ -166.76M $ -111.51M Cost of Revenue $ $ $ Net Cash Flow $ $ 152.03M $ 2.5M PE Ratio     Splits Jun 25, 2013:   1:6